ANGO R&D to Revenue
Angiodynamics Inc · R&D to Revenue
ANGO R&D to Revenue
Latest reported9.20%period ending
ANGO FY R&D/Revenue (6.10% → 9.20%)
Latest values, visible window
High-resolution chart · PNG
ANGO r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 9.1972% | |
| 8.9648% | |
| 10.3687% | |
| 8.8215% | |
| 9.7208% | |
| 12.5047% | |
| 11.2365% | |
| 8.1881% | |
| 7.3947% | |
| 7.2271% | |
| 7.104% | |
| 7.5442% | |
| 7.7612% | |
| 7.695% | |
| 9.2481% | |
| 9.8964% | |
| 8.9222% | |
| 9.1841% | |
| 8.6631% | |
| 18.3156% | |
| 7.4811% | |
| 7.5802% | |
| 7.2388% | |
| 6.5281% | |
| 6.316% | |
| 6.0966% |